… , end-to-end services for antibody-drug conjugates (ADCs) – from discovery … timelines by enabling both Monoclonal Antibodies (mAb) production and GMP bioconjugation …

… producing lots of broadly neutralizing antibodies. The new study was … various doses of two antibody-producing plasmids and injection schedules … in the amount of antibody produced, but that amount … boosted the level of antibody production. But even the …

… The Human Combinatorial Antibody Libraries Market? Growth in therapeutic antibodies: Targeting challenging … . In neurosciences, antibody libraries enable the discovery of antibodies targeting neurological disorders …

… candidate. Abzena’s scientists screened antibodies against a number of parameters … manufacturing cell line for this antibody was generated for manufacture. … designing, developing, and manufacturing monoclonal antibody programs.  The organization can support …

… , an anti-tau antibody that targets specific tau … an anti-amyloid β protofibril antibody, lecanemab (Leqembi; Eisai), in … microtubule binding region) Tau Antibody Etalanetug Granted FDA Fast … microtubule-binding-region-tau-antibody-etalanetug-granted-fda-fast …

… the Full Potential of Antibody Diversity Traditional antibody discovery depends on … ” targets. • Accelerated timelines: Lead antibody identification reduced from 12–18 … : Produces high-affinity, stable antibodies suitable for therapeutic, diagnostic and …

… Pharmaceutical Co. Ltd. have synthesized antibody-drug conjugates (ADCs) comprising a … claudin 6 (CLDN6)-targeting antibody linked to cytotoxic drug through … ovarian cancer. BioWorld Science Cancer Antibody-drug conjugate Patents

… discovery of fully human therapeutic antibodies. The collaboration will help scientists … . Collaborating with MSK on antibody discovery represents a powerful opportunity … engineered mouse models (GEMMs), the immunoglobulin gene-humanized mouse model- NeoMab …

… index of Zymeworks’ novel antibody-drug conjugate platform Dose optimization … engineer and develop highly differentiated antibody-based therapeutic candidates. Zymeworks … in both antibody drug conjugates and multispecific antibody therapeutics targeting …

… animal models revealed the modified antibody bound immune cells more strongly … , difficult to activate with unmodified antibodies. We found our triple-engineered … . (2025). An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune …